Auditory phenotype of niemann-pick disease, type C1

Ear and Hearing

Volumn 35, Issue 1, 2014, Pages 110-117

  King, Kelly A ^a   Gordon Salant, Sandra ^b   Yanjanin, Nicole ^c   Zalewski, Christopher ^a   Houser, Ari ^b   Porter, Forbes D ^c   Brewer, Carmen C ^a  

^a NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Auditory phenotype; Hearing; Niemann Pick Type C; NPC

Indexed keywords

1 DEOXYNOJIRIMYCIN; CRESOL; DRUG DERIVATIVE; ENZYME INHIBITOR; FORMALDEHYDE; MIGLUSTAT; PHENOALDEHYDE; RESORCINOL DERIVATIVE;

ADOLESCENT; ARTICLE; CHILD; COHORT ANALYSIS; DISEASE COURSE; DRUG COMBINATION; EVOKED BRAIN STEM AUDITORY RESPONSE; FEMALE; HEARING IMPAIRMENT; HUMAN; INFANT; LONGITUDINAL STUDY; MALE; NIEMANN PICK DISEASE; PATHOPHYSIOLOGY; PHYSIOLOGY; PRESCHOOL CHILD; PURE TONE AUDIOMETRY; SPEECH PERCEPTION; SPONTANEOUS OTOACOUSTIC EMISSION; STATISTICAL MODEL; YOUNG ADULT;

1-DEOXYNOJIRIMYCIN; ADOLESCENT; AUDIOMETRY, PURE-TONE; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; CRESOLS; DISEASE PROGRESSION; DRUG COMBINATIONS; ENZYME INHIBITORS; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; FEMALE; FORMALDEHYDE; HEARING LOSS; HUMANS; INFANT; LINEAR MODELS; LONGITUDINAL STUDIES; MALE; NIEMANN-PICK DISEASE, TYPE C; OTOACOUSTIC EMISSIONS, SPONTANEOUS; RESORCINOLS; SPEECH PERCEPTION; YOUNG ADULT;

EID: 84891836071     PISSN: 01960202     EISSN: 15384667     Source Type: Journal    
DOI: 10.1097/AUD.0b013e3182a362b8     Document Type: Article

References (28)

1. Aisen, M., Rapoport, S., Solomon, G. (1985). Brain stem auditory evoked potentials in two siblings with Niemann-Pick disease. Brain Dev, 7, 431-433.
2. ANSI. (2010). S3.1-1999 American National Standard Maximum Permissible Ambient Noise Levels for Audiometric Test Rooms (Standard S3.1). New York, NY: American National Standards Institute.
3. Attias, J., Buller, N., Rubel, Y., et al. (2006). Multiple auditory steady-state responses in children and adults with normal hearing, sensorineural hearing loss, or auditory neuropathy. Ann Otol Rhinol Laryngol, 115, 268-276.
4. Carstea, E. D., Morris, J. A., Coleman, K. G., et al. (1997). Niemann-Pick C1 disease gene: Homology to mediators of cholesterol homeostasis. Science, 277, 228-231.
5. Clark, J. G. (1981). Uses and abuses of hearing loss classification. ASHA, 23, 493-500.
6. Fink, J. K., Filling-Katz, M. R., Sokol, J., et al. (1989). Clinical spectrum of Niemann-Pick disease type C. Neurology, 39, 1040-1049.
7. Garver, W. S., Francis, G. A., Jelinek, D., et al. (2007). The National Niemann-Pick C1 disease database: Report of clinical features and health problems. Am J Med Genet A, 143A, 1204-1211.
8. Gelfand, S. A. (2009). Essentials of Audiology (3rd ed.). New York, NY: Thieme Medical Publishers, Inc.
9. th percentiles in a large sample. J Speech Hear Disord, 55, 198-205.
10. Hall, J. W. (1992). Test protocols and procedures. In J. W. Hall, (1st eds.). Handbook of Auditory Evoked Responses (pp. 277-304). Needham Heights, MA: Allyn and Bacon.
11. Higgins, J. J., Patterson, M. C., Dambrosia, J. M., et al. (1992). A clinical staging classification for type C Niemann-Pick disease. Neurology, 42, 2286-2290.
12. Hood, L.J. (1998). Clinical applications of the ABR in neurological testing. In L. J. Hood, Clinical Applications of the Auditory Brainstem Response (pp. 67-91). Clifton Park, NY: Singular Publishing Group.
13. Ikonen, E., & Hölttä-Vuori, M. (2004). Cellular pathology of Niemann-Pick type C disease. Semin Cell Dev Biol, 15, 445-454.
14. Issa, A., & Ross, H. F. (1995). An improved procedure for assessing ABR latency in young subjects based on a new normative data set. Int J Pediatr Otorhinolaryngol, 32, 35-47.
15. Liscum, L., & Faust, J. R. (1987). Low density lipoprotein (LDL)-mediated suppression of cholesterol synthesis and LDL uptake is defective in Niemann-Pick type C fibroblasts. J Biol Chem, 262, 17002-17008.
16. Liscum, L., Ruggiero, R. M., Faust, J. R. (1989). The intracellular transport of low density lipoprotein-derived cholesterol is defective in Niemann-Pick type C fibroblasts. J Cell Biol, 108, 1625-1636.
17. Margolis, R. H., & Heller, J. W. (1987). Screening tympanometry: Criteria for medical referral. Audiology, 26, 197-208.
18. Naureckiene, S., Sleat, D. E., Lackland, H., et al. (2000). Identification of HE1 as the second gene of Niemann-Pick C disease. Science, 290, 2298-2301.
19. Ornitz, E. M., & Walter, D. O. (1975). The effect of sound pressure waveform on human brain stem evoked responses. Brain Research, 92, 490-498.
20. Palmeri, S., Tarugi, P., Sicurelli, F., et al. (2005). Lung involvement in Niemann-Pick disease type C1: Improvement with bronchoalveolar lavage. Neurol Sci, 26, 171-173.
21. Pikus, A. (1991). Audiologic profile in Niemann-Pick C. Ann N Y Acad Sci, 630, 313-314.
22. Ramirez, C. M., Liu, B., Taylor, A. M., et al. (2010). Weekly cyclodextrin administration normalizes cholesterol metabolism in nearly every organ of the Niemann-Pick type C1 mouse and markedly prolongs life. Pediatr Res, 68, 309-315.
23. Runz, H. (2012). Niemann-Pick Type C Disease Gene Variation Database. Retrieved from http://npc.fzk.de/
24. Schwartz, D. M., Pratt, R. E. Jr, Schwartz, J. A. (1989). Auditory brain stem responses in preterm infants: Evidence of peripheral maturity. Ear Hear, 10, 14-22.
25. Vanier, M. T., & Millat, G. (2003). Niemann-Pick disease type C. Clin Genet, 64, 269-281.
26. Vincent, I., Bu, B., Erickson, R. P. (2003). Understanding Niemann-Pick type C disease: A fat problem. Curr Opin Neurol, 16, 155-161.
27. Ward, S., O'Donnell, P., Fernandez, S., et al. (2010). 2-Hydroxypropylß-Cyclodextrin raises hearing threshold in normal cats and in cats with Niemann-Pick type C disease. Pediatr Res, 68(1), 52-56.
28. Yanjanin, N. M., Vélez, J. I., Gropman, A., et al. (2010). Linear clinical progression, independent of age of onset, in Niemann-Pick disease, type C. Am J Med Genet B Neuropsychiatr Genet, 153B, 132-140.